vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1495Research ArticleОБМЕН ОПЫТОМEXCHANGE OF EXPERIENCEЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ПРИМЕНЕНИЯ ПИМЕКРОЛИМУСА ПРИ АТОПИЧЕСКОМ ДЕРМАТИТЕ У ДЕТЕЙ И ПОДРОСТКОВEFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTSМонаховК.Н.MonakhovK.N.ОчеленкоС.А.OchelenkoS.A.Санкт-Петербургский медицинский университет им. И.П. ПавловаРоссияI.P. Pavlov St.9Petersburg Medical UniversityRussian Federation20080611201576Вопросы современной педиатрии141144Copyright © Монахов К., Очеленко С., 20082008Монахов К., Очеленко С.Monakhov K., Ochelenko S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1495ReferencesAshcroft D., Dimmock P., Garside R. et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta–analysis of randomised controlled trials. BMJ. 2005; 330 (7490): 516.Ashcroft D., Dimmock P., Garside R. et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta–analysis of randomised controlled trials. BMJ. 2005; 330 (7490): 516.Williams H., Robertson C., Stewart A. et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J. Allergy Clin. Immunol. 1999; 103 (1): 125–138.Williams H., Robertson C., Stewart A. et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J. Allergy Clin. Immunol. 1999; 103 (1): 125–138.Laughter D., Istvan J., Tofte S. et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 2000; 43 (4): 649–655.Laughter D., Istvan J., Tofte S. et al. The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 2000; 43 (4): 649–655.Jennifer D., Peterson M., Lawrence S. et al. A comprehensive management guide for atopic dermatitis. Dermatol. Nurs. 2006; 18 (6): 531–542.Jennifer D., Peterson M., Lawrence S. et al. A comprehensive management guide for atopic dermatitis. Dermatol. Nurs. 2006; 18 (6): 531–542.Sulzberger M., Witten V. The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol. 1952; 19 (2): 101–102.Sulzberger M., Witten V. The effect of topically applied compound F in selected dermatoses. J. Invest. Dermatol. 1952; 19 (2): 101–102.Hengge U., Ruzicka T., Schwartz R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 2006; 54 (1): 1–15.Hengge U., Ruzicka T., Schwartz R. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 2006; 54 (1): 1–15.Giusti F., Martella A., Bertoni L. et al. Skin barrier, hydration, and PH of the skin of infants under 2 years of age. Pediatr. Derm. 2001; 18 (2): 93–96.Giusti F., Martella A., Bertoni L. et al. Skin barrier, hydration, and PH of the skin of infants under 2 years of age. Pediatr. Derm. 2001; 18 (2): 93–96.Walsh P., Aeling G., Huff L. et al. Hypotalamus pituitary adrenal axis suppression by superpotent steroids. J. Am. Acad. Dermatol. 1993; 29 (3): 501–503.Walsh P., Aeling G., Huff L. et al. Hypotalamus pituitary adrenal axis suppression by superpotent steroids. J. Am. Acad. Dermatol. 1993; 29 (3): 501–503.Корсунская И.М., Дворянкова Е.В. Новые препараты в местной терапии атопического дерматита. Consilium Medicum. 2004; 6 (3): 14–17.Корсунская И.М., Дворянкова Е.В. Новые препараты в местной терапии атопического дерматита. Consilium Medicum. 2004; 6 (3): 14–17.Stuetz A., Grassberg M., Meingasser J. Pimecrolimus (Elidel, SDZ ASM 981) – preclinical pharmacologic profile and skin selectivity. Semin. Cutan. Med. Surg. 2001; 20 (4): 233–241.Stuetz A., Grassberg M., Meingasser J. Pimecrolimus (Elidel, SDZ ASM 981) – preclinical pharmacologic profile and skin selectivity. Semin. Cutan. Med. Surg. 2001; 20 (4): 233–241.Kalthoff F., Meingassner J., Chung J. et al. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity. J. Dermatol. Sci. 2006; 43 (2): 117–126.Kalthoff F., Meingassner J., Chung J. et al. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity. J. Dermatol. Sci. 2006; 43 (2): 117–126.Reuters Health Information 2006. Pimecrolimus cream provides fast relief of pruritus. Allergy. 2006; 61: 375–381.Reuters Health Information 2006. Pimecrolimus cream provides fast relief of pruritus. Allergy. 2006; 61: 375–381.
The authors declare that there are no conflicts of interest present.